Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Xếp hạng trong cổ phiếu #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Giá cổ phiếu
$154.51
Vốn hóa thị trường
$55.98B
Thay đổi (1 ngày)
-1.82%
Thay đổi (1 năm)
-32.08%
Quốc gia
US
Giao dịch Becton, Dickinson and Company (BDX)

Danh mục

Thu nhập của Becton, Dickinson and Company (BDX)
Thu nhập trong Dec 2025 TTM: $2.06B
Theo báo cáo tài chính gần đây của Becton, Dickinson and Company, lợi nhuận hiện tại của công ty là $2.06B. Năm 2024, công ty đạt được lợi nhuận là $2.01B, tăng so với lợi nhuận năm 2023 là $1.66B. Lợi nhuận hiển thị trên trang này là lợi nhuận trước lãi vay và thuế, hay còn gọi là EBIT.
Lịch sử thu nhập của Becton, Dickinson and Company từ 2000 đến 2026
Thu nhập vào cuối mỗi năm
Năm Thu nhập Thay đổi
2026 (TTM) $2.06B 9.62%
2025 $1.88B -6.13%
2024 $2.01B 20.64%
2023 $1.66B -6.79%
2022 $1.78B 5.38%
2021 $1.69B 308.70%
2020 $414.00M -64.80%
2019 $1.18B 0.26%
2018 $1.17B 20.18%
2017 $976.00M -9.12%
2016 $1.07B 45.33%
2015 $739.00M -51.45%
2014 $1.52B 30.64%
2013 $1.17B -20.86%
2012 $1.47B -9.02%
2011 $1.62B 3.27%
2010 $1.57B -0.75%
2009 $1.58B 2.61%
2008 $1.54B 27.78%
2007 $1.20B 6.93%
2006 $1.13B 12.05%
2005 $1.00B 33.47%
2004 $752.87M 4.28%
2003 $721.96M 15.06%
2002 $627.47M 8.79%
2001 $576.75M 10.93%
2000 $519.93M 0.00%
Thu nhập của các công ty hoặc đối thủ tương tự
Công ty Thu nhập Chênh lệch thu nhập Quốc gia
$3.31B 60.51%
US
$394.38M -80.88%
DE
$2.05B -0.80%
JP
$1.16B -43.77%
CH
$1.82B -11.84%
US